Sunshine Biopharma Inc (NASDAQ:SBFM) traded at $1.42 at last check on current trade day and made an upward move of 13.61% on its previous day’s price.
Looking at the stock we see that its previous close was $1.25 and the beta (5Y monthly) reads 0.384 with the day’s price range being $1.31 – $1.54. In terms of its 52-week price range, SBFM has a high of $73.60 and a low of $1.17. The company’s stock has lost about -36.32% over that past 30 days.
Sunshine Biopharma Inc has a market cap of $5.16 million and is expected to release its quarterly earnings report on 2025-Mar-31.
According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 100M, or 186.74% up from figures reported last year.
On the other hand, looking at the outlook for the SBFM stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell.
Looking further, we note the current price level is -15.85% off its SMA20 and -31.02% from its 50-day simple moving average. The RSI (14) is pointing at 37.41 while the volatility over the past week is 8.60% and jumps to 14.88% over the past one month. The beta value is 1.38, while the average true range (ATR) is currently pointing at 0.23.
Coming back to Sunshine Biopharma Inc (NASDAQ:SBFM), we note that the average 3-month trading volume was 1.21 million, while that of the preceding 10-day period stands at 0.24 million. Current shares outstanding are 3.64 million.
The insiders hold 0.08% of the company’s shares while institutions hold 4.53%. The data shows that short shares as of 2025-03-31, stood at 0.14 million at a short ratio of 4.35. This represents a 522.00 short interest in shares outstanding on 2025-03-31. Shares short rose in March from the previous month at 63487.0. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -52.66% down in year-to-date price movement.
